Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected]..
Expert Opin Drug Metab Toxicol. 10(6), 787-812.
(2014). Multiple myeloma: interplay between osteoblastogenesis and adipogenesis..
Eur J Haematol. 86(5), 447-8.
(2011). Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib..
Clin Cancer Res. 15(23), 7153-60.
(2009). Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition..
J Clin Endocrinol Metab. 92(12), 4845-52.
(2007). Intense [18F]FDG tongue uptake in a case of acipimox-related angio-oedema during FDG-PET myocardial viability study..
Eur J Nucl Med Mol Imaging. 34(8), 1320-1.
(2007). The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro..
Invest Ophthalmol Vis Sci. 48(10), 4706-19.
(2007). Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro..
J Clin Endocrinol Metab. 91(10), 4013-21.
(2006). Successful treatment of lymph node extramedullary plasmacytoma with bortezomib..
Ann Hematol. 85(3), 188-90.
(2006).